Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Global - Biologics Market (Billion US$), 2010-2015
Figure 3-2: Global - Biologics Market by Segment (%), 2010
Figure 3-3: Global - Share of Country/Region in Biologics Market
Figure 5-1: Global - Biosimilars Market (Million US$), 2010 & 2015
Figure 5-2: Global - Biosimilars Market by Key Segment (%), 2010
Figure 5-3: Global - Erythropoietin Biosimilars Market (Million US$), 2010-2015
Figure 5-4: Global - HGH Biosimilars Market (Million US$), 2010-2015
Figure 5-5: Global - G-CSF Biosimilars Market (Million US$), 2010-2015

List of Tables:

Table 4-1: Global - Pipeline Biosimilar Products of Key Players against Cancer
Table 5-1: Global - Marketed EPO Biosimilar Products of Key Players
Table 5-2: Global - Pipeline EPO Biosimilar Products of Key Players
Table 5-3: Global - Marketed HGH Biosimilar Products of Key Players
Table 5-4: Global - Marketed G-CSF Biosimilar Products of Key Players
Table 5-5: Global - Pipeline G-CSF Biosimilar Products of Key Players
Table 5-6: Global - Marketed mAb Biosimilar Products of Key Players
Table 5-7: Global - Pipeline mAB Biosimilar Products of Key Players
Table 5-8: Global - Marketed Insulin Biosimilar Products of Key Players
Table 5-9: Global - Pipeline Insulin Biosimilar Products of Key Players
Table 5-10: Global - Marketed Interferon Biosimilar Products of Key Players
Table 5-11: Global - Pipeline Interferon Biosimilar Products of Key Players
Table 6-1: US - Annual Prescription Costs/Person for Key Biologics
Table 6-2: US - Patent Expiries of Key Biologics
Table 6-3: Europe - Approved Biosimilar Products (2010)
Table 6-4: Europe - Patent Expiries of Key Biologics
Table 6-5: India - Key Approved Biosimilar Products
Table 6-6: China - Key Approved Biosimilar Products
Table 6-7: Korea - Key Approved Biosimilar Products
Table 6-8: Korea - Key Biosimilar Products in Pipeline
Table 6-9: Korea - Patent Expiries of Key Biologics